80% of breast cancer patients are cured.
What do you have to do to get cured?
You must rigorously follow the treatments and healthy lifestyle recommendations that your oncologist has prescribed for as long as indicated, even if there are side effects. It is important to be able to live with the side effects of medication. However, more than 50% of women with breast cancer drop out of treatment. This is due to pain and other side effects, assuming the risk of relapses and other complications.
One of the main reasons for abandoning post-surgery treatments is joint pain. Many women with breast cancer see their quality of life deteriorated for a prolonged period of time due to the effects of hormonal treatments such as aromatase inhibitors or tamoxifen, treatments that can last from 5 to 10 years. These treatments cannot be avoided or interrupted. But they carry side effects such as joint pain that accompany daily mild to severe pain.
WHY DO MANY WOMEN WHO HAVE OVERCOME BREAST CANCER HAVE JOINT PAIN?
In this video from the VIII INTERNATIONAL COURSE ON BREAST CANCER SURGERY the Dr. Noelia MartinezShe makes a presentation of great value, because she is a vocational professional who works every day with people who suffer joint discomfort (arthralgias), but in addition his specialty is the Medical Oncology at the Ramón y Cajal University Hospital and its daily goal is to help breast cancer patients to have a better life, because in addition to surviving, you have to live. A professional explanation of the relationship between breast cancer and inflammation and the treatment of arthralgias.
Dr. Martinez explains how OLIMINA3 is a natural dietary supplement, which in a clinical study, has been shown to be effective in reducing joint discomfort. The combination of its three components in the right measure, the way in which they are extracted and treated, which makes it effective, safe, without side effects even when taken continuously and chronically, without the need for possible adverse effects.
Dr. Martinez explains it in detail, here we summarize it for you. The clinical study with Olimina3 (conducted at La Paz, Ramón y Cajal, Puerta de Hierro and Quirón hospitals) tested the anti-inflammatory power of each of the three compounds in the exact combination that gives rise to Olimina3 and the results are statistically significant and encouraging, they showed:
- 70% of patients had a reduction in inflammation indicators.
- High pain reduction, according to BPI pain scale.
Olimina3 Part 1 Breast cancer and inflammation Treatment of arthralgias
Olimina3 Part2 Clinical study, dietary supplements
